Yvette H. van Beurden

679 citations

13 papers · 467 indexed · h-index 12

Gastroenterology top 5%
- Celiac Disease Research and Management 1
Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research 12
- Viral gastroenteritis research and epidemiology 1
Critical Care and Intensive Care Medicine top 10%
- Nosocomial Infections in ICU 4
Epidemiology
- Microscopic Colitis 13
Applied Microbiology and Biotechnology
Surgery
- Helicobacter pylori-related gastroenterology studies 7
General Health Professions
- Healthcare cost, quality, practices 1

Co-authors: Abraham Goorhuis Josbert J. Keller Chris J. Mulder Elisabeth M. Terveer Christina M. J. E. Vandenbroucke‐Grauls Ed J. Kuijper Els van Nood Martijn P. Bauer
Cited by: Gastroenterology Infectious Diseases Critical Care and Intensive Care Medicine
Journals: PLoS ONE (1 paper)Clinical Microbiology and Infection (3 papers)Infection Control and Hospital Epidemiology (1 paper)
Partner nations: Netherlands United States

In The Last Decade

Yvette H. van Beurden

13 papers receiving 460 citations

Peers

Countries citing papers authored by Yvette H. van Beurden

Since Specialization

Citations

This map shows the geographic impact of Yvette H. van Beurden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette H. van Beurden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette H. van Beurden more than expected).

Fields of papers citing papers by Yvette H. van Beurden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvette H. van Beurden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette H. van Beurden. The network helps show where Yvette H. van Beurden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yvette H. van Beurden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yvette H. van Beurden Line = papers co-authored together Yvette H. van Beurden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection Therapeutic Advances in Gastroenterology ·Tessel M. van Rossen,Laura J. van Dijk,Martijn W. Heymans,Olaf M. Dekkers,Christina M. J. E. Vandenbroucke‐Grauls,Yvette H. van Beurden	2021	11
2	Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature Microorganisms ·Rogier E. Ooijevaar,Els van Nood,Abraham Goorhuis,Elisabeth M. Terveer,Joffrey van Prehn,Hein W. Verspaget,Yvette H. van Beurden,Marcel G. W. Dijkgraaf,Josbert J. Keller	2021	14
3	Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank United European Gastroenterology Journal ·Elisabeth M. Terveer,Karuna E.W. Vendrik,Rogier E. Ooijevaar,Emilie van Lingen,Eline Boeije‐Koppenol,Els van Nood,Abraham Goorhuis,Martijn P. Bauer,Yvette H. van Beurden,Marcel G. W. Dijkgraaf,Chris J. Mulder,Christina M. J. E. Vandenbroucke‐Grauls,Jos F. M. L. Seegers,Joffrey van Prehn,Hein W. Verspaget,Ed J. Kuijper,Josbert J. Keller	2020	35
4	Update of treatment algorithms for Clostridium difficile infection Clinical Microbiology and Infection ·Rogier E. Ooijevaar,Yvette H. van Beurden,Elisabeth M. Terveer,Abraham Goorhuis,Martijn P. Bauer,Josbert J. Keller,Chris J. Mulder,Ed J. Kuijper	2018	92
5	Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Clinical Microbiology and Infection ·Yvette H. van Beurden,S. Nezami,Chris J. Mulder,Christina M. J. E. Vandenbroucke‐Grauls	2017	14
6	How to: Establish and run a stool bank Clinical Microbiology and Infection ·Elisabeth M. Terveer,Yvette H. van Beurden,Abraham Goorhuis,Jos F. M. L. Seegers,Martijn P. Bauer,Els van Nood,M.G.W. Dijkgraaf,Chris J. Mulder,Christina M. J. E. Vandenbroucke‐Grauls,Hein W. Verspaget,Josbert J. Keller,Ed J. Kuijper	2017	118
7	External Validation of Three Prediction Tools for Patients at Risk of a Complicated Course of Clostridium difficile Infection: Disappointing in an Outbreak Setting Infection Control and Hospital Epidemiology ·Yvette H. van Beurden,M.P.M. Hensgens,Olaf M. Dekkers,Saskia le Cessie,Chris J. Mulder,Christina M. J. E. Vandenbroucke‐Grauls	2017	10
8	Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation Therapeutic Advances in Gastroenterology ·Yvette H. van Beurden,Max Nieuwdorp,Pablo J. E. J. van de Berg,Chris J. Mulder,Abraham Goorhuis	2017	30
9	Complications, effectiveness, and long term follow‐up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection United European Gastroenterology Journal ·Yvette H. van Beurden,Pieter F. de Groot,Els van Nood,Max Nieuwdorp,Josbert J. Keller,Abraham Goorhuis	2016	60
10	An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study PLoS ONE ·Yvette H. van Beurden,Olaf M. Dekkers,Marije K. Bomers,A.M. Kaiser,Robin van Houdt,Cornelis W. Knetsch,Armand R. J. Girbes,Chris J. Mulder,Christina M. J. E. Vandenbroucke‐Grauls	2016	15
11	Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre Journal of Hospital Infection ·Yvette H. van Beurden,Marije K. Bomers,Suzanne D. van der Werff,Edwin A. Pompe,S. Spiering,Christina M. J. E. Vandenbroucke‐Grauls,Chris J. Mulder	2016	15
12	Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer Journal of Gastrointestinal and Liver Diseases ·Yvette H. van Beurden,Tom van Gils,Nienke A. Van Gils,Zain Kassam,Chris J. Mulder,Nieves Aparicio-Pagés	2016	38
13	Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting European Journal of Clinical Microbiology & Infectious Diseases ·Joffrey van Prehn,Christina M. J. E. Vandenbroucke‐Grauls,Yvette H. van Beurden,Robin van Houdt,Seppo Vainio,C. Wim Ang	2015	15

About Yvette H. van Beurden

Yvette H. van Beurden is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases and Epidemiology, having authored 13 papers that have together received 467 indexed citations. Recurring topics across this work include Microscopic Colitis (13 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Nosocomial Infections in ICU (4 papers), Viral gastroenteritis research and epidemiology (1 paper), Healthcare cost, quality, practices (1 paper) and Celiac Disease Research and Management (1 paper). The work is most often cited by research in Gastroenterology (134 citations), Infectious Diseases (401 citations) and Critical Care and Intensive Care Medicine (53 citations). Yvette H. van Beurden has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Abraham Goorhuis, Josbert J. Keller, Chris J. Mulder, Elisabeth M. Terveer, Christina M. J. E. Vandenbroucke‐Grauls, Ed J. Kuijper, Els van Nood, Martijn P. Bauer, Max Nieuwdorp and Chris J. Mulder. Their work appears in journals such as PLoS ONE, Clinical Microbiology and Infection and Infection Control and Hospital Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact